{"ABBV": {"Ticker": "ABBV", "Company": "AbbVie", "Sector": "Health Care", "Updated": "2022-02-28", "Rating": [{"Date": "2022-02-28", "Rating": "Downgrade", "Organization": "UBS", "Rating_Change": "Buy to Neutral", "Target_Change": "$129 to $147"}, {"Date": "2022-02-03", "Rating": "Reiterated", "Organization": "Goldman", "Rating_Change": "Neutral", "Target_Change": "$117 to $122"}, {"Date": "2022-02-03", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Neutral", "Target_Change": "$135 to $138"}, {"Date": "2022-02-03", "Rating": "Reiterated", "Organization": "BMO Capital Markets", "Rating_Change": "Outperform", "Target_Change": "$153 to $154"}, {"Date": "2022-02-03", "Rating": "Reiterated", "Organization": "Barclays", "Rating_Change": "Equal Weight", "Target_Change": "$133 to $150"}, {"Date": "2022-01-13", "Rating": "Initiated", "Organization": "Redburn", "Rating_Change": "Buy", "Target_Change": ""}, {"Date": "2022-01-12", "Rating": "Reiterated", "Organization": "BMO Capital Markets", "Rating_Change": "Outperform", "Target_Change": "$134 to $153"}, {"Date": "2021-12-09", "Rating": "Resumed", "Organization": "Wells Fargo", "Rating_Change": "Overweight", "Target_Change": "$165"}], "Score": 0.88, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 8, "Period": "180 days", "Analists": ["Goldman", "UBS", "BMO Capital Markets", "Wells Fargo", "Redburn", "Barclays", "BofA Securities"], "Price_Target": 127.62}, "AEP": {"Ticker": "AEP", "Company": "American Electric Power", "Sector": "Utilities", "Updated": "2022-02-28", "Rating": [{"Date": "2022-02-28", "Rating": "Upgrade", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight to Overweight", "Target_Change": "$93 to $101"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Analists": ["Wells Fargo"], "Price_Target": 101.0}, "BBY": {"Ticker": "BBY", "Company": "Best Buy", "Sector": "Consumer Discretionary", "Updated": "2022-02-28", "Rating": [{"Date": "2022-02-28", "Rating": "Reiterated", "Organization": "Telsey Advisory Group", "Rating_Change": "Outperform", "Target_Change": "$150 to $125"}, {"Date": "2022-01-13", "Rating": "Initiated", "Organization": "Truist", "Rating_Change": "Hold", "Target_Change": "$108"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Analists": ["Telsey Advisory Group", "Truist"], "Price_Target": 116.5}, "DLTR": {"Ticker": "DLTR", "Company": "Dollar Tree", "Sector": "Consumer Discretionary", "Updated": "2022-02-28", "Rating": [{"Date": "2022-02-28", "Rating": "Upgrade", "Organization": "BMO Capital Markets", "Rating_Change": "Market Perform to Outperform", "Target_Change": "$155 to $170"}, {"Date": "2022-02-23", "Rating": "Reiterated", "Organization": "Telsey Advisory Group", "Rating_Change": "Outperform", "Target_Change": "$175 to $180"}, {"Date": "2022-01-13", "Rating": "Initiated", "Organization": "Truist", "Rating_Change": "Buy", "Target_Change": "$162"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Analists": ["Telsey Advisory Group", "BMO Capital Markets", "Truist"], "Price_Target": 170.67}, "GILD": {"Ticker": "GILD", "Company": "Gilead Sciences", "Sector": "Health Care", "Updated": "2022-02-28", "Rating": [{"Date": "2022-02-28", "Rating": "Downgrade", "Organization": "BMO Capital Markets", "Rating_Change": "Outperform to Market Perform", "Target_Change": "$75 to $65"}, {"Date": "2022-02-02", "Rating": "Reiterated", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight", "Target_Change": "$72 to $70"}, {"Date": "2022-02-02", "Rating": "Reiterated", "Organization": "Truist", "Rating_Change": "Hold", "Target_Change": "$77 to $75"}, {"Date": "2022-02-02", "Rating": "Reiterated", "Organization": "RBC Capital Mkts", "Rating_Change": "Outperform", "Target_Change": "$87 to $85"}, {"Date": "2022-02-02", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Neutral", "Target_Change": "$73 to $71"}, {"Date": "2022-02-02", "Rating": "Reiterated", "Organization": "BMO Capital Markets", "Rating_Change": "Outperform", "Target_Change": "$85 to $75"}, {"Date": "2022-01-28", "Rating": "Upgrade", "Organization": "Argus", "Rating_Change": "Hold to Buy", "Target_Change": ""}, {"Date": "2022-01-06", "Rating": "Downgrade", "Organization": "Morgan Stanley", "Rating_Change": "Overweight to Equal-Weight", "Target_Change": "$84 to $74"}, {"Date": "2021-12-09", "Rating": "Resumed", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight", "Target_Change": "$72"}, {"Date": "2021-12-06", "Rating": "Initiated", "Organization": "Goldman", "Rating_Change": "Neutral", "Target_Change": "$80"}], "Score": 0.2, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 10, "Period": "180 days", "Analists": ["Goldman", "BMO Capital Markets", "RBC Capital Mkts", "Argus", "Morgan Stanley", "Wells Fargo", "BofA Securities", "Truist"], "Price_Target": 65.7}, "LMT": {"Ticker": "LMT", "Company": "Lockheed Martin", "Sector": "Industrials", "Updated": "2022-02-28", "Rating": [{"Date": "2022-02-28", "Rating": "Upgrade", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform to Outperform", "Target_Change": ""}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Analists": ["Wolfe Research"], "Price_Target": -1.0}, "PHM": {"Ticker": "PHM", "Company": "PulteGroup", "Sector": "Consumer Discretionary", "Updated": "2022-02-28", "Rating": [{"Date": "2022-02-28", "Rating": "Upgrade", "Organization": "BofA Securities", "Rating_Change": "Underperform to Buy", "Target_Change": ""}, {"Date": "2022-02-03", "Rating": "Upgrade", "Organization": "UBS", "Rating_Change": "Neutral to Buy", "Target_Change": "$63 to $70"}, {"Date": "2022-01-20", "Rating": "Initiated", "Organization": "UBS", "Rating_Change": "Neutral", "Target_Change": "$63"}], "Score": 1.67, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Analists": ["BofA Securities", "UBS"], "Price_Target": 43.33}, "UHS": {"Ticker": "UHS", "Company": "Universal Health Services", "Sector": "Health Care", "Updated": "2022-02-28", "Rating": [{"Date": "2022-02-28", "Rating": "Downgrade", "Organization": "Seaport Research Partners", "Rating_Change": "Buy to Neutral", "Target_Change": ""}, {"Date": "2022-01-10", "Rating": "Resumed", "Organization": "Citigroup", "Rating_Change": "Buy", "Target_Change": "$160 to $162"}], "Score": 0.5, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Analists": ["Citigroup", "Seaport Research Partners"], "Price_Target": 80.0}}